Advertisement

Clinical Reviews in Allergy & Immunology

, Volume 40, Issue 1, pp 66–73 | Cite as

Estrogen Receptors in Immunity and Autoimmunity

  • Melissa Cunningham
  • Gary Gilkeson
Article

Abstract

Due to the female predominance of autoimmune diseases, the role of gender and sex hormones in the immune system is of long-term interest. Estrogen's primary effects are mediated via estrogen receptors alpha and beta (ER α/β) that are expressed on most immune cells. ERs are nuclear hormone receptors that can either directly bind to estrogen response elements in gene promoters or serve as cofactors with other transcription factors (i.e., NFkB/AP1). Cytoplasmic ER and membrane associated ER impact specific kinase signaling pathways. ERs have prominent effects on immune function in both the innate and adaptive immune responses. Genetic deficiency of ERα in murine models of lupus resulted in significantly decreased disease and prolonged survival, while ERβ deficiency had minimal to no effect in autoimmune models. The protective effect of ERα in lupus is multifactoral. In arthritis models, ERα agonists appears to mediate a protective effect. The modulation of ERα function appears to be a potential target for therapy in autoimmunity.

Keywords

Estrogen receptors Autoimmunity Gender prevalence 

Notes

Acknowledgements

This work was supported by a Merit Review Award and a REAP award from the Veterans Administration Medical Research Service.

References

  1. 1.
    Jensen EV, Block GE, Smith S, Kyser K, DeSombre ER (1971) Estrogen receptors and breast cancer response to adrenalectomy. Natl Cancer Inst Monogr 34:55–70PubMedGoogle Scholar
  2. 2.
    Jensen EV, Suzuki T, Numata M, Smith S, DeSombre ER (1969) Estrogen-binding substances of target tissues. Steroids 13(4):417–427CrossRefPubMedGoogle Scholar
  3. 3.
    Walter P, Green S, Greene G et al (1985) Cloning of the human estrogen receptor cDNA. Proc Natl Acad Sci USA 82(23):7889–7893CrossRefPubMedGoogle Scholar
  4. 4.
    Jensen EV, Desombre ER, Kawashima T, Suzuki T, Kyser K, Jungblut PW (1967) Estrogen-binding substances of target tissues. Science 158(3800):529–530CrossRefPubMedGoogle Scholar
  5. 5.
    Jensen EV, Hurst DJ, DeSombre ER, Jungblut PW (1967) Sulfhydryl groups and estradiol-receptor interaction. Science 158(799):385–387CrossRefPubMedGoogle Scholar
  6. 6.
    Couse JF, Lindzey J, Grandien K, Gustafsson JA, Korach KS (1997) Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology 138(11):4613–4621CrossRefPubMedGoogle Scholar
  7. 7.
    Tamrazi A, Carlson KE, Daniels JR, Hurth KM, Katzenellenbogen JA (2002) Estrogen receptor dimerization: ligand binding regulates dimer affinity and dimer dissociation rate. Mol Endocrinol 16(12):2706–2719CrossRefPubMedGoogle Scholar
  8. 8.
    Biswas DK, Singh S, Shi Q, Pardee AB, Iglehart JD (2005) Crossroads of estrogen receptor and NF-kappaB signaling. Sci STKE 2005(288):pe27CrossRefPubMedGoogle Scholar
  9. 9.
    Jakacka M, Ito M, Martinson F, Ishikawa T, Lee EJ, Jameson JL (2002) An estrogen receptor (ER)alpha deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo. Mol Endocrinol 16(10):2188–2201CrossRefPubMedGoogle Scholar
  10. 10.
    Jakacka M, Ito M, Weiss J, Chien PY, Gehm BD, Jameson JL (2001) Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway. J Biol Chem 276(17):13615–13621PubMedGoogle Scholar
  11. 11.
    Safe S (2001) Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions. Vitam Horm 62:231–252CrossRefPubMedGoogle Scholar
  12. 12.
    Wang Z, Zhang X, Shen P, Loggie BW, Chang Y, Deuel TF (2005) Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66. Biochem Biophys Res Commun 336(4):1023–1027CrossRefPubMedGoogle Scholar
  13. 13.
    Moriarty K, Kim KH, Bender JR (2006) Minireview: estrogen receptor-mediated rapid signaling. Endocrinology 147(12):5557–5563CrossRefPubMedGoogle Scholar
  14. 14.
    Bunone G, Briand PA, Miksicek RJ, Picard D (1996) Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 15(9):2174–2183PubMedGoogle Scholar
  15. 15.
    Lannigan DA (2003) Estrogen receptor phosphorylation. Steroids 68(1):1–9CrossRefPubMedGoogle Scholar
  16. 16.
    Karpuzoglu E, Zouali M (2009) The multi-faceted influences of estrogen on lymphocytes: toward novel immuno-interventions strategies for autoimmunity management. Clin Rev Allergy Immunol. doi: 10.1007/s12016-009-8188-0
  17. 17.
    Pernis AB (2007) Estrogen and CD4+ T cells. Curr Opin Rheumatol 19(5):414–420CrossRefPubMedGoogle Scholar
  18. 18.
    Salem ML (2004) Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production. Current drug targets 3(1):97–104CrossRefPubMedGoogle Scholar
  19. 19.
    Inui A, Ogasawara H, Naito T et al (2007) Estrogen receptor expression by peripheral blood mononuclear cells of patients with systemic lupus erythematosus. Clin Rheumatol 26(10):1675–1678CrossRefPubMedGoogle Scholar
  20. 20.
    Rider V, Li X, Peterson G, Dawson J, Kimler BF, Abdou NI (2006) Differential expression of estrogen receptors in women with systemic lupus erythematosus. J Rheumatol 33(6):1093–1101PubMedGoogle Scholar
  21. 21.
    Stygar D, Westlund P, Eriksson H, Sahlin L (2006) Identification of wild type and variants of oestrogen receptors in polymorphonuclear and mononuclear leucocytes. Clin Endocrinol 64(1):74–81CrossRefGoogle Scholar
  22. 22.
    Smithson G, Medina K, Ponting I, Kincade PW (1995) Estrogen suppresses stromal cell-dependent lymphopoiesis in culture. J Immunol 155(7):3409–3417PubMedGoogle Scholar
  23. 23.
    Stimson WH (1988) Oestrogen and human T lymphocytes: presence of specific receptors in the T-suppressor/cytotoxic subset. Scand J Immunol 28(3):345–350CrossRefPubMedGoogle Scholar
  24. 24.
    Kawashima I, Seiki K, Sakabe K, Ihara S, Akatsuka A, Katsumata Y (1992) Localization of estrogen receptors and estrogen receptor-mRNA in female mouse thymus. Thymus 20(2):115–121PubMedGoogle Scholar
  25. 25.
    Haruki Y, Seiki K, Enomoto T, Fujii H, Sakabe K (1983) Estrogen receptor in the “non-lymphocytes” in the thymus of the ovariectomized rat. Tokai J Exp Clin Med 8(1):31–39PubMedGoogle Scholar
  26. 26.
    Igarashi H, Kouro T, Yokota T, Comp PC, Kincade PW (2001) Age and stage dependency of estrogen receptor expression by lymphocyte precursors. Proc Natl Acad Sci USA 98(26):15131–15136CrossRefPubMedGoogle Scholar
  27. 27.
    Shim GJ, Gherman D, Kim HJ et al (2006) Differential expression of oestrogen receptors in human secondary lymphoid tissues. J Pathol 208(3):408–414CrossRefPubMedGoogle Scholar
  28. 28.
    Phiel KL, Henderson RA, Adelman SJ, Elloso MM (2005) Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations. Immunol Lett 97(1):107–113CrossRefPubMedGoogle Scholar
  29. 29.
    Carlsten H, Nilsson N, Jonsson R, Backman K, Holmdahl R, Tarkowski A (1992) Estrogen accelerates immune complex glomerulonephritis but ameliorates T cell-mediated vasculitis and sialadenitis in autoimmune MRL lpr/lpr mice. Cell Immunol 144(1):190–202CrossRefPubMedGoogle Scholar
  30. 30.
    Kouro T, Medina KL, Oritani K, Kincade PW (2001) Characteristics of early murine B-lymphocyte precursors and their direct sensitivity to negative regulators. Blood 97(9):2708–2715CrossRefPubMedGoogle Scholar
  31. 31.
    Medina KL, Smithson G, Kincade PW (1993) Suppression of B lymphopoiesis during normal pregnancy. J Exp Med 178(5):1507–1515CrossRefPubMedGoogle Scholar
  32. 32.
    Medina KL, Strasser A, Kincade PW (2000) Estrogen influences the differentiation, proliferation, and survival of early B-lineage precursors. Blood 95(6):2059–2067PubMedGoogle Scholar
  33. 33.
    Medina KL, Kincade PW (1994) Pregnancy-related steroids are potential negative regulators of B lymphopoiesis. Proc Natl Acad Sci USA 91(12):5382–5386CrossRefPubMedGoogle Scholar
  34. 34.
    Wilson CA, Mrose SA, Thomas DW (1995) Enhanced production of B lymphocytes after castration. Blood 85(6):1535–1539PubMedGoogle Scholar
  35. 35.
    Masuzawa T, Miyaura C, Onoe Y et al (1994) Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow. J Clin Invest 94(3):1090–1097CrossRefPubMedGoogle Scholar
  36. 36.
    Thurmond TS, Murante FG, Staples JE, Silverstone AE, Korach KS, Gasiewicz TA (2000) Role of estrogen receptor alpha in hematopoietic stem cell development and B lymphocyte maturation in the male mouse. Endocrinology 141(7):2309–2318CrossRefPubMedGoogle Scholar
  37. 37.
    Smithson G, Couse JF, Lubahn DB, Korach KS, Kincade PW (1998) The role of estrogen receptors and androgen receptors in sex steroid regulation of B lymphopoiesis. J Immunol 161(1):27–34PubMedGoogle Scholar
  38. 38.
    Erlandsson MC, Jonsson CA, Islander U, Ohlsson C, Carlsten H (2003) Oestrogen receptor specificity in oestradiol-mediated effects on B lymphopoiesis and immunoglobulin production in male mice. Immunology 108(3):346–351CrossRefPubMedGoogle Scholar
  39. 39.
    Okasha SA, Ryu S, Do Y, McKallip RJ, Nagarkatti M, Nagarkatti PS (2001) Evidence for estradiol-induced apoptosis and dysregulated T cell maturation in the thymus. Toxicology 163(1):49–62CrossRefPubMedGoogle Scholar
  40. 40.
    Rijhsinghani AG, Thompson K, Bhatia SK, Waldschmidt TJ (1996) Estrogen blocks early T cell development in the thymus. Am J Reprod Immunol 36(5):269–277PubMedGoogle Scholar
  41. 41.
    Staples JE, Gasiewicz TA, Fiore NC, Lubahn DB, Korach KS, Silverstone AE (1999) Estrogen receptor alpha is necessary in thymic development and estradiol-induced thymic alterations. J Immunol 163(8):4168–4174PubMedGoogle Scholar
  42. 42.
    Erlandsson MC, Ohlsson C, Gustafsson JA, Carlsten H (2001) Role of oestrogen receptors alpha and beta in immune organ development and in oestrogen-mediated effects on thymus. Immunology 103(1):17–25CrossRefPubMedGoogle Scholar
  43. 43.
    Maret A, Coudert JD, Garidou L et al (2003) Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor alpha expression in hematopoietic cells. Eur J Immunol 33(2):512–521CrossRefPubMedGoogle Scholar
  44. 44.
    Bebo BF Jr, Fyfe-Johnson A, Adlard K, Beam AG, Vandenbark AA, Offner H (2001) Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J Immunol 166(3):2080–2089PubMedGoogle Scholar
  45. 45.
    Delpy L, Douin-Echinard V, Garidou L, Bruand C, Saoudi A, Guery JC (2005) Estrogen enhances susceptibility to experimental autoimmune myasthenia gravis by promoting type 1-polarized immune responses. J Immunol 175(8):5050–5057PubMedGoogle Scholar
  46. 46.
    Tai P, Wang J, Jin H et al (2008) Induction of regulatory T cells by physiological level estrogen. J Cell Physiol 214(2):456–464CrossRefPubMedGoogle Scholar
  47. 47.
    Polanczyk MJ, Carson BD, Subramanian S et al (2004) Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment. J Immunol 173(4):2227–2230PubMedGoogle Scholar
  48. 48.
    Polanczyk MJ, Hopke C, Huan J, Vandenbark AA, Offner H (2005) Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice. J Neuroimmunol 170(1–2):85–92CrossRefPubMedGoogle Scholar
  49. 49.
    Nalbandian G, Kovats S (2005) Understanding sex biases in immunity: effects of estrogen on the differentiation and function of antigen-presenting cells. Immunol Res 31(2):91–106CrossRefPubMedGoogle Scholar
  50. 50.
    Salem ML, Matsuzaki G, Kishihara K, Madkour GA, Nomoto K (2000) Beta-estradiol suppresses T cell-mediated delayed-type hypersensitivity through suppression of antigen-presenting cell function and Th1 induction. Int Arch Allergy Immunol 121(2):161–169CrossRefPubMedGoogle Scholar
  51. 51.
    Saito S, Foegh ML, Motomura N, Lou H, Kent K, Ramwell PW (1998) Estradiol inhibits allograft-inducible major histocompatibility complex class II antigen expression and transplant arteriosclerosis in the absence of immunosuppression. Transplantation 66(11):1424–1431CrossRefPubMedGoogle Scholar
  52. 52.
    Wira CR, Roche MA, Rossoll RM (2002) Antigen presentation by vaginal cells: role of TGFbeta as a mediator of estradiol inhibition of antigen presentation. Endocrinology 143(8):2872–2879CrossRefPubMedGoogle Scholar
  53. 53.
    Hoek A, Allaerts W, Leenen PJ, Schoemaker J, Drexhage HA (1997) Dendritic cells and macrophages in the pituitary and the gonads. Evidence for their role in the fine regulation of the reproductive endocrine response. Eur J Endocrinol/European Federation of Endocrine Societies 136(1):8–24Google Scholar
  54. 54.
    Medina KL, Garrett KP, Thompson LF, Rossi MI, Payne KJ, Kincade PW (2001) Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen. Nature immunology 2(8):718–724CrossRefPubMedGoogle Scholar
  55. 55.
    Prabhala RH, Wira CR (1995) Sex hormone and IL-6 regulation of antigen presentation in the female reproductive tract mucosal tissues. J Immunol 155(12):5566–5573PubMedGoogle Scholar
  56. 56.
    Mao A, Paharkova-Vatchkova V, Hardy J, Miller MM, Kovats S (2005) Estrogen selectively promotes the differentiation of dendritic cells with characteristics of Langerhans cells. J Immunol 175(8):5146–5151PubMedGoogle Scholar
  57. 57.
    Mor G, Sapi E, Abrahams VM et al (2003) Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes. J Immunol 170(1):114–122PubMedGoogle Scholar
  58. 58.
    Komi J, Lassila O (2000) Nonsteroidal anti-estrogens inhibit the functional differentiation of human monocyte-derived dendritic cells. Blood 95(9):2875–2882PubMedGoogle Scholar
  59. 59.
    Harkonen PL, Vaananen HK (2006) Monocyte-macrophage system as a target for estrogen and selective estrogen receptor modulators. Ann N Y Acad Sci 1089:218–227CrossRefPubMedGoogle Scholar
  60. 60.
    Sapi E, Brown WD, Aschkenazi S et al (2002) Regulation of Fas ligand expression by estrogen in normal ovary. J Soc Gynecol Investig 9(4):243–250CrossRefPubMedGoogle Scholar
  61. 61.
    Paharkova-Vatchkova V, Maldonado R, Kovats S (2004) Estrogen preferentially promotes the differentiation of CD11c+CD11b(intermediate) dendritic cells from bone marrow precursors. J Immunol 172(3):1426–1436PubMedGoogle Scholar
  62. 62.
    Carreras E, Turner S, Paharkova-Vatchkova V, Mao A, Dascher C, Kovats S (2008) Estradiol acts directly on bone marrow myeloid progenitors to differentially regulate GM-CSF or Flt3 ligand-mediated dendritic cell differentiation. J Immunol 180(2):727–738PubMedGoogle Scholar
  63. 63.
    Siracusa MC, Overstreet MG, Housseau F, Scott AL, Klein SL (2008) 17beta-estradiol alters the activity of conventional and IFN-producing killer dendritic cells. J Immunol 180(3):1423–1431PubMedGoogle Scholar
  64. 64.
    Carreras E, Turner S, Frank MB et al (2010) Estrogen receptor signaling promotes dendritic cell differentiation by increasing expression of the transcription factor IRF4. Blood 115(2):238–246Google Scholar
  65. 65.
    Bengtsson AA, Sturfelt G, Truedsson L et al (2000) Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 9(9):664–671CrossRefPubMedGoogle Scholar
  66. 66.
    Vallin H, Blomberg S, Alm GV, Cederblad B, Ronnblom L (1999) Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-alpha (IFN-alpha) production acting on leucocytes resembling immature dendritic cells. Clin Exp Immunol 115(1):196–202CrossRefPubMedGoogle Scholar
  67. 67.
    Ding D, Mehta H, McCune WJ, Kaplan MJ (2006) Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus. J Immunol 177(9):5878–5889PubMedGoogle Scholar
  68. 68.
    Zhu J, Liu X, Xie C et al (2005) T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells. J Clin Invest 115(7):1869–1878CrossRefPubMedGoogle Scholar
  69. 69.
    Crispin JC, Alcocer-Varela J (2007) The role myeloid dendritic cells play in the pathogenesis of systemic lupus erythematosus. Autoimmun Rev 6(7):450–456CrossRefPubMedGoogle Scholar
  70. 70.
    Bouman A, Moes H, Heineman MJ, de Leij LF, Faas MM (2001) The immune response during the luteal phase of the ovarian cycle: increasing sensitivity of human monocytes to endotoxin. Fertil Steril 76(3):555–559CrossRefPubMedGoogle Scholar
  71. 71.
    Brannstrom M, Friden BE, Jasper M, Norman RJ (1999) Variations in peripheral blood levels of immunoreactive tumor necrosis factor alpha (TNFalpha) throughout the menstrual cycle and secretion of TNFalpha from the human corpus luteum. Eur J Obstet Gynecol Reprod Biol 83(2):213–217CrossRefPubMedGoogle Scholar
  72. 72.
    Cannon JG, Dinarello CA (1985) Increased plasma interleukin-1 activity in women after ovulation. Science 227(4691):1247–1249CrossRefPubMedGoogle Scholar
  73. 73.
    Polan ML, Loukides JA, Honig J (1994) Interleukin-1 in human ovarian cells and in peripheral blood monocytes increases during the luteal phase: evidence for a midcycle surge in the human. Am J Obstet Gynecol 170(4):1000–1006, discussion 6-7PubMedGoogle Scholar
  74. 74.
    Bouman A, Heineman MJ, Faas MM (2005) Sex hormones and the immune response in humans. Hum Reprod Updat 11(4):411–423CrossRefGoogle Scholar
  75. 75.
    Weusten JJ, Blankenstein MA, Gmelig-Meyling FH, Schuurman HJ, Kater L, Thijssen JH (1986) Presence of oestrogen receptors in human blood mononuclear cells and thymocytes. Acta endocrinologica 112(3):409–414PubMedGoogle Scholar
  76. 76.
    Suenaga R, Evans MJ, Mitamura K, Rider V, Abdou NI (1998) Peripheral blood T cells and monocytes and B cell lines derived from patients with lupus express estrogen receptor transcripts similar to those of normal cells. J Rheumatol 25(7):1305–1312PubMedGoogle Scholar
  77. 77.
    Suenaga R, Mitamura K, Evans MJ, Abdou NI (1996) Binding affinity and quantity of estrogen receptor in peripheral blood monocytes of patients with systemic lupus erythematosus. Lupus 5(3):227–231CrossRefPubMedGoogle Scholar
  78. 78.
    Murphy AJ, Guyre PM, Wira CR, Pioli PA (2009) Estradiol regulates expression of estrogen receptor ERalpha46 in human macrophages. PloS one 4(5):e5539CrossRefPubMedGoogle Scholar
  79. 79.
    Engdahl C, Jochems C, Windahl SH et al (2010) Amelioration of collagen-induced arthritis and immune-associated bone loss through signaling via estrogen receptor alpha, and not estrogen receptor beta or G protein-coupled receptor 30. Arthritis Rheum 62(2):524–533Google Scholar
  80. 80.
    van Vollenhoven RF, Houbiers JG, Buttgereit F et al (2010) The selective estrogen receptor alpha agonist Org 37663 induces estrogenic effects but lacks antirheumatic activity: A phase IIa trial investigating efficacy and safety of Org 37663 in postmenopausal female rheumatoid arthritis patients receiving stable background methotrexate or sulfasalazine. Arthritis Rheum 62(2):351–358Google Scholar
  81. 81.
    Talal N (1982) Sex hormones and modulation of immune response in SLE. Clin Rheum Dis 8(1):23–28PubMedGoogle Scholar
  82. 82.
    Talal N (1981) Sex steroid hormones and systemic lupus erythematosus. Arthritis Rheum 24(8):1054–1056CrossRefPubMedGoogle Scholar
  83. 83.
    Shim GJ, Kis LL, Warner M, Gustafsson JA (2004) Autoimmune glomerulonephritis with spontaneous formation of splenic germinal centers in mice lacking the estrogen receptor alpha gene. Proc Natl Acad Sci USA 101(6):1720–1724CrossRefPubMedGoogle Scholar
  84. 84.
    Bynote KK, Hackenberg JM, Korach KS, Lubahn DB, Lane PH, Gould KA (2008) Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB x NZW)F1 mice. Genes Immun 9(2):137–152CrossRefPubMedGoogle Scholar
  85. 85.
    Svenson JL, EuDaly J, Ruiz P, Korach KS, Gilkeson GS (2008) Impact of estrogen receptor deficiency on disease expression in the NZM2410 lupus prone mouse. Clin Immunol 128(2):259–268CrossRefPubMedGoogle Scholar
  86. 86.
    Apelgren LD, Bailey DL, Fouts RL et al (1996) The effect of a selective estrogen receptor modulator on the progression of spontaneous autoimmune disease in MRL lpr/lpr mice. Cell Immunol 173(1):55–63CrossRefPubMedGoogle Scholar
  87. 87.
    Johansson M, Arlestig L, Moller B, Smedby T, Rantapaa-Dahlqvist S (2005) Oestrogen receptor alpha gene polymorphisms in systemic lupus erythematosus. Ann Rheum Dis 64(11):1611–1617CrossRefPubMedGoogle Scholar
  88. 88.
    Lee YJ, Shin KS, Kang SW et al (2004) Association of the oestrogen receptor alpha gene polymorphisms with disease onset in systemic lupus erythematosus. Ann Rheum Dis 63(10):1244–1249CrossRefPubMedGoogle Scholar
  89. 89.
    Graham RR, Hom G, Ortmann W, Behrens TW (2009) Review of recent genome-wide association scans in lupus. J Intern Med 265(6):680–688CrossRefPubMedGoogle Scholar
  90. 90.
    Buyon JP (1996) Oral contraceptives in women with systemic lupus erythematosus. Ann Med Interne (Paris) 147(4):259–264Google Scholar
  91. 91.
    Buyon JP (1998) Hormone replacement therapy in postmenopausal women with systemic lupus erythematosus. J Am Med Womens Assoc 53(1):13–17PubMedGoogle Scholar
  92. 92.
    Sturgess AD, Evans DT, Mackay IR, Riglar A (1984) Effects of the oestrogen antagonist tamoxifen on disease indices in systemic lupus erythematosus. J Clin Lab Immunol 13(1):11–14PubMedGoogle Scholar
  93. 93.
    Abdou NI, Rider V, Greenwell C, Li X, Kimler BF (2008) Fulvestrant (Faslodex), an estrogen selective receptor downregulator, in therapy of women with systemic lupus erythematosus. clinical, serologic, bone density, and T cell activation marker studies: a double-blind placebo-controlled trial. J Rheumatol 35(5):797PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Medical Research Service, Ralph H. Johnson VAMC and the Department of Medicine, Division of RheumatologyMedical University of South CarolinaCharlestonUSA

Personalised recommendations